欧盟官方标签名称词汇表条目 6213
CHLORHEXIDINE DIGLUCONATE
本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。
全球证据概览
所解析的身份在 13 个已索引市场数据集中的 2 个有匹配的监管证据:2 条国家记录和 0 条欧盟附件记录。下方列出每项结果和证据缺口。
已检查的市场
13
有证据的市场
2
证据缺口
11
已解析的标识符
2
已解析的物质身份
CAS:18472-51-0
EC:242-354-0
成分索引记录:
CHLORHEXIDINE DIGLUCONATE
Ph. Eur. 名称: chlorhexidini gluconati solutio
化妆品功能: ANTIMICROBIAL, ORAL CARE, PRESERVATIVE
D-Gluconic acid, compound with N,N''-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1)
清单限制备注: V/42
5 个匹配或报告的名称
CHLORHEXIDINE DIGLUCONATEchlorhexidine gluconatechlorhexidini gluconati solutioN,N″-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13tetraazatetradecanediamidine (chlorhexidine) and its digluconate, diacetate, and dihydrochloride e.g. chlorhexidine digluconateChlorhexidine gluconate
全部 13 个市场的监管证据
打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。
滑动或横向滚动以查看数据集覆盖范围和后续操作。
| 市场 | 结果 | 记录 | 数据集 | 含义 / 后续操作 |
|---|---|---|---|---|
| European Union EU | 未找到匹配项 | 0 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review. |
| Great Britain GB | 未找到匹配项 | 0 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework. |
| Canada CA | 未找到匹配项 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Permitted list with conditions | 1打开记录 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | 请查看每条关联记录及其确切条件。 |
| ASEAN ASEAN | 未找到匹配项 | 0 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Regional annex coverage does not replace member-state implementation dates, notifications or national deviations. |
| China CN | 未找到匹配项 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | Restricted | 1打开记录 1 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | 请查看每条关联记录及其确切条件。 |
| South Korea KR | 未找到匹配项 | 0 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Korean source wording is canonical and other positive lists/notices may still apply to the formulation. |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | 未找到匹配项 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | 未找到匹配项 | 0 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | The standards are separate controlled publications; absence from a locally indexed excerpt is not permission. |
| Saudi Arabia SA | 未找到匹配项 | 0 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply. |
没有与此筛选条件匹配的市场行。
匹配的市场记录和条件
Japan
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot化学身份与性质

CAS 18472-51-0PubChem CID 9552081
Chlorhexidine Gluconate
Chlorhexidine gluconate is a D-gluconate adduct and an organochlorine compound. It has a role as an antibacterial agent. It is functionally related to a chlorhexidine. — ChEBI
- IUPAC 名称
- (1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine;bis((2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid)
- 分子式
- C34H54Cl2N10O14
- 分子量
- 897.8 g/mol
- 精确质量
- 896.3198018 Da
- 拓扑极性表面积
- 454.0 Ų
- 氢键供体
- 18
- 氢键受体
- 16
- 共价单元
- 3
- 已定义的立体中心
- 8
又称
CHLORHEXIDINE DIGLUCONATEHibiclensDyna-hexBioscrubHibistatMicrodermPeriochipPeriogard
另有 16 个已报告名称
ExidineChlorhexidine D-digluconateBrian CareSteri-StatCida-StatBacticlensCorsodylHibidilKleersightPrevacarePharmaseal Scrub CareCHG SCRUBFight bacPrevacare RChlorhexidine di-D-gluconateMOR84MUD8E
外部数据库标识符
- ChEBI:CHEBI:28312
- ChEMBL:CHEMBL4297088
- EPA DTXSID:DTXSID5034519
- PubMed:33358762
- PubMed:23551508
- PubMed:22615282
- PubMed:18245686
- PubMed:16566965
- PubMed:15324357
- PubMed:10321611
- PubMed:9759061
- PubMed:2465403
- PubMed:1191923
- PubMed:1009330
- PubMed:145039
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与范围
导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。
打开官方决定